SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (4332)5/19/1998 11:30:00 AM
From: PAL  Read Replies (1) | Respond to of 6136
 
Steve, AGPH is mentioned in today's IBD issue "New America" as one of the companies which is developing anti cancer drug. Genetech is on the top with Phase III while Agouron is right below it with AG3340 (funny for typo AG2240) in Phase II/III. This article might account for the small rise in the stock.